The precise pathophysiological activity of the IL-33/ST2 signaling pathway in neurodegenerative diseases should be further explored, and IL-33 could be a promising prognostic marker and therapeutic target for neurodegenerative disorders [34]. This evidence concerns the gene IL33 and neurodegenerative disease.